Asian drug market stocks slides: Trump’s 100% pharmaceutical tariffs shake market; broader impact on Japan likely minimal
Asian drug stocks fell on Friday as investors reacted to US President Donald Trump’s threat to impose 100% tariffs on imported branded pharmaceuticals starting October 1.Companies without existing US manufacturing plants could face the full impact, triggering declines across major drugmakers in South Korea, Japan, and Hong Kong.In South Korea, Samsung Biologics fell 1.6%, while…